Overview
Uğur Şahin is a ntech specialist with an H-index of 103 at Bio (Member). Has been published in New England Journal of Medicine, Nature, Nature Reviews Drug Discovery. Based in Unknown, Unknown, Global.
Biography
Uğur Şahin is a German medical researcher, entrepreneur, and businessman. He is the co-founder and CEO of BioNTech, which developed the world’s first mRNA-based vaccine against COVID-19. He also serves as chairman of the scientific management board of the Helmholtz Institute for Translational Oncology (HI-TRON), a Mainz-based cutting-edge biopharmaceutical research laboratory he co-founded in 2018. He is co-inventor of more than 500 filed patents applications and patents. His main fields of research are cancer research and immunology.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
N Engl J MedNatureScienceNat Rev Drug Discov
Key Publications
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
mRNA-based therapeutics--developing a new class of drugs.
Identification of neoantigens for individualized therapeutic cancer vaccines.
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Media Archive